Sonja Eberle
Overview
Explore the profile of Sonja Eberle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dempfle C, Koscielny J, Lindhoff-Last E, Linnemann B, Bux-Gewehr I, Kappert G, et al.
Clin Appl Thromb Hemost
. 2021 May;
27:10760296211014575.
PMID: 33942675
We analyzed data for women who received fondaparinux for ≥7 days during pregnancy. The study retrospectively included women who received fondaparinux pre-, peri- and/or postpartum for ≥7 days for prophylaxis/venous...
2.
Schindewolf M, Steindl J, Beyer-Westendorf J, Schellong S, Dohmen P, Brachmann J, et al.
J Am Coll Cardiol
. 2017 Nov;
70(21):2636-2648.
PMID: 29169470
Background: Life-threatening heparin-induced thrombocytopenia (HIT) is treated with the alternative nonheparin anticoagulants argatroban, lepirudin, or danaparoid. Frequently, the pentasaccharide fondaparinux is used off-label. Objectives: The authors sought to investigate the...
3.
Hach-Wunderle V, Bauersachs R, Gerlach H, Eberle S, Schellong S, Riess H, et al.
J Vasc Surg Venous Lymphat Disord
. 2016 Mar;
1(1):5-12.
PMID: 26993886
Background: Reported post-thrombotic syndrome (PTS) rates may be confounded by including patients with a history of deep venous thrombosis (DVT) before the index event, varicose veins, or chronic venous insufficiency...
4.
Schindewolf M, Steindl J, Beyer-Westendorf J, Schellong S, Dohmen P, Brachmann J, et al.
Thromb Res
. 2014 Apr;
134(1):29-35.
PMID: 24703295
Introduction: In life-threatening immune heparin-induced thrombocytopenia (HIT), treatment with an approved non-heparin anticoagulant is essential. However, off-label use with fondaparinux has been reported in the literature. The study aim was...
5.
Matzdorff A, Arnold G, Salama A, Ostermann H, Eberle S, Hummler S
PLoS One
. 2011 Nov;
6(11):e27350.
PMID: 22096556
Background: Current guidelines recommend glucocorticoids and splenectomy as standard 1(st) and 2(nd) line treatments for chronic immune thrombocytopenia (ITP). We sought to find out how German ITP-patients are treated with...
6.
Iftner T, Eberle S, Iftner A, Holz B, Banik N, Quint W, et al.
J Med Virol
. 2010 Sep;
82(11):1928-39.
PMID: 20872721
Human papillomavirus (HPV) infection is frequent in young women and persistent infection may lead to cervical cancer. Therefore, vaccination against HPV is recommended for young women in the age group...
7.
Bauersachs R, Riess H, Hach-Wunderle V, Gerlach H, Carnarius H, Eberle S, et al.
Thromb Haemost
. 2010 Feb;
103(4):710-7.
PMID: 20174769
It is uncertain whether gender influences the clinical presentation of deep-vein thrombosis (DVT) and the discriminative value of the Wells diagnostic pretest probability score. The aim of the study was...
8.
Schellong S, Gerlach H, Hach-Wunderle V, Rabe E, Riess H, Carnarius H, et al.
Thromb Haemost
. 2009 Dec;
102(6):1234-40.
PMID: 19967156
Current guidelines recommend optimised algorithms for diagnosis of suspected deep-vein thrombosis (DVT). There is little data to determine to what extent real-world health care adheres to guidelines, and which outcome...
9.
Kastrati A, Dibra A, Eberle S, Mehilli J, de Lezo J, Goy J, et al.
JAMA
. 2005 Aug;
294(7):819-25.
PMID: 16106007
Context: Placement of sirolimus-eluting stents or paclitaxel-eluting stents has emerged as the predominant percutaneous treatment strategy in patients with coronary artery disease (CAD). Whether there are any differences in efficacy...